Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $5 Price Target
Cantor Fitzgerald analyst Sarah James reiterates Nano X Imaging (NASDAQ:NNOX) with a Overweight and maintains $5 price target.
Read original at benzingaStocks · News reference
Nanox Imaging's Nanox AI Subsidiary Signs Reseller Agreement With Vertec Scientific To Commercialize Nanox.AI Bone Solution In U.K.
Nanox Imaging Ltd. ("Nanox", or the "Company" NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced its subsidiary, Nanox AI Ltd. ("Nanox AI") entered into a sales
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 18, 2026, 12:11 PM
- Checked
- Aug 18, 2026, 12:11 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Nano-X Imaging CEO And Director Erez Meltzer Buys 9,443 Ordinary Shares At $1.03 Per Share
https://www.sec.gov/Archives/edgar/data/1371973/000121390026087547/xslF345X06/ownership.xml
Read original at benzingaNanox AI Optimizes Medical Imaging AI For On-Premise Edge Inference With Intel Core Ultra And OpenVINO
On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel’s OpenVINO toolkit to accelerate edge inference within healthcare environmentsPETACH TIKVA, Israel – August 10 – Nanox AI Ltd., a
Read original at benzinga